Bridgewater Associates’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-29,167
| Closed | -$687K | – | 760 |
|
2022
Q4 | $687K | Sell |
29,167
-8,554
| -23% | -$201K | ﹤0.01% | 686 |
|
2022
Q3 | $984K | Buy |
37,721
+1,245
| +3% | +$32.5K | 0.01% | 701 |
|
2022
Q2 | $801K | Buy |
36,476
+4,373
| +14% | +$96K | ﹤0.01% | 831 |
|
2022
Q1 | $1.44M | Buy |
32,103
+7,679
| +31% | +$344K | 0.01% | 748 |
|
2021
Q4 | $1.05M | Sell |
24,424
-46
| -0.2% | -$1.97K | 0.01% | 565 |
|
2021
Q3 | $1.63M | Sell |
24,470
-1,508
| -6% | -$100K | 0.01% | 464 |
|
2021
Q2 | $1.91M | Buy |
+25,978
| New | +$1.91M | 0.01% | 498 |
|